These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 30192094)

  • 1. Management of common adverse effects of antipsychotic medications.
    Stroup TS; Gray N
    World Psychiatry; 2018 Oct; 17(3):341-356. PubMed ID: 30192094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent effects of antipsychotics on efficacy and adverse effects in schizophrenia.
    Yoshida K; Takeuchi H
    Behav Brain Res; 2021 Mar; 402():113098. PubMed ID: 33417992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticholinergic medication for antipsychotic-induced tardive dyskinesia.
    Bergman H; Soares-Weiser K
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD000204. PubMed ID: 29341071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical complications of new antipsychotic drugs.
    Umbricht D; Kane JM
    Schizophr Bull; 1996; 22(3):475-83. PubMed ID: 8873298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrapyramidal symptoms with atypical antipsychotics : incidence, prevention and management.
    Pierre JM
    Drug Saf; 2005; 28(3):191-208. PubMed ID: 15733025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical guide to antipsychotic drugs.
    Schwartz JT; Brotman AW
    Drugs; 1992 Dec; 44(6):981-92. PubMed ID: 1282868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deuterium Tetrabenazine for Tardive Dyskinesia.
    Cummings MA; Proctor GJ; Stahl SM
    Clin Schizophr Relat Psychoses; 2018 Jan; 11(4):214-220. PubMed ID: 29341821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic intolerance.
    Hansen TE; Casey DE; Hoffman WF
    Schizophr Bull; 1997; 23(4):567-82. PubMed ID: 9365996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.
    Maher AR; Theodore G
    J Manag Care Pharm; 2012 Jun; 18(5 Suppl B):S1-20. PubMed ID: 22784311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
    J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Recommendations for Tardive Dyskinesia.
    Ricciardi L; Pringsheim T; Barnes TRE; Martino D; Gardner D; Remington G; Addington D; Morgante F; Poole N; Carson A; Edwards M
    Can J Psychiatry; 2019 Jun; 64(6):388-399. PubMed ID: 30791698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse effects of antipsychotic drugs.
    Malhotra AK; Litman RE; Pickar D
    Drug Saf; 1993 Dec; 9(6):429-36. PubMed ID: 7907481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic-induced tardive dyskinesia: update on epidemiology and management.
    Widschwendter CG; Hofer A
    Curr Opin Psychiatry; 2019 May; 32(3):179-184. PubMed ID: 30720484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel blockers for antipsychotic-induced tardive dyskinesia.
    Essali A; Soares-Weiser K; Bergman H; Adams CE
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD000206. PubMed ID: 29578611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse effects of antipsychotic medications.
    Muench J; Hamer AM
    Am Fam Physician; 2010 Mar; 81(5):617-22. PubMed ID: 20187598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive Dyskinesia-Key Differences in Pathophysiology and Clinical Management.
    Ward KM; Citrome L
    Neurol Ther; 2018 Dec; 7(2):233-248. PubMed ID: 30027457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse effects of the atypical antipsychotics. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998; 59 Suppl 12():17-22. PubMed ID: 9766615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia.
    Hauser RA; Factor SA; Marder SR; Knesevich MA; Ramirez PM; Jimenez R; Burke J; Liang GS; O'Brien CF
    Am J Psychiatry; 2017 May; 174(5):476-484. PubMed ID: 28320223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia.
    Barnes TR; McPhillips MA
    Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S49-57. PubMed ID: 9690971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.